FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2903033182> ?p ?o ?g. }

• W2903033182 abstract "Abstract Cantharidin, one of the active components of mylabris, is believed to have antitumor activity. Cantharidin selectively inhibits protein phosphatase 2A (PP2A), which can repress multiple oncogenic kinases (ERK, JNK, PKC, and NF-κB). Researches in vitro have shown that cantharidin suppresses cell viability and metastasis in pancreatic cancer cells. This study aims to investigate the effects of cantharidin on pancreatic cancer xenografts in vivo. Xenograft models were established using cells stably expressing luciferase. Xenograft growth was evaluated by living imaging. Gene expression was determined using a microarray, real-time PCR, a RayBiotech antibody array, and the Milliplex assay. Surprisingly, cantharidin significantly accelerated xenograft growth. Living imaging showed a rapid distribution of D-luciferin in cantharidin-treated xenografts, suggesting a rich blood supply. Immunohistochemistry confirmed increased angiogenesis. Microarray and antibody array identified upregulated proangiogenic and downregulated antiangiogenic factors. The Milliplex assay suggested elevated secretion of IL-6, IL-8, TNF-α, and VEGF. Inhibitors of ERK, JNK, PKC, and NF-κB pathway attenuated the cantharidin-induced changes to proangiogenic gene expression. PKC pathway-inhibiting tamoxifen or antiangiogenic therapeutics, including Ginsenoside Rg3, bevacizumab, Apatinib, and Endostar, antagonized the proangiogenic effect of cantharidin or its derivatives. These regimens presented remarkable additive antitumor effects in vivo. Although cantharidin presents antitumor effects in vitro and has been applied in clinical practice, we revealed an unfavorable proangiogenic side effect. We recommend that the clinical application of cantharidin should be performed on the premise of antivascularization therapy." @default.
• W2903033182 created "2018-12-11" @default.
• W2903033182 creator A5000432967 @default.
• W2903033182 creator A5002004920 @default.
• W2903033182 creator A5007948709 @default.
• W2903033182 creator A5008989960 @default.
• W2903033182 creator A5034329447 @default.
• W2903033182 creator A5036274384 @default.
• W2903033182 creator A5049264813 @default.
• W2903033182 creator A5058203745 @default.
• W2903033182 creator A5073087120 @default.
• W2903033182 creator A5074339191 @default.
• W2903033182 creator A5077934134 @default.
• W2903033182 creator A5080012876 @default.
• W2903033182 creator A5082986499 @default.
• W2903033182 date "2018-11-26" @default.
• W2903033182 modified "2023-10-17" @default.
• W2903033182 title "The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer" @default.
• W2903033182 cites W1488829562 @default.
• W2903033182 cites W1979487623 @default.
• W2903033182 cites W1981076681 @default.
• W2903033182 cites W1989453119 @default.
• W2903033182 cites W1993344078 @default.
• W2903033182 cites W1996852003 @default.
• W2903033182 cites W2030993868 @default.
• W2903033182 cites W2032458681 @default.
• W2903033182 cites W2032596261 @default.
• W2903033182 cites W2037624217 @default.
• W2903033182 cites W2038638713 @default.
• W2903033182 cites W2057967638 @default.
• W2903033182 cites W2059860479 @default.
• W2903033182 cites W2077536394 @default.
• W2903033182 cites W2081697027 @default.
• W2903033182 cites W2083102682 @default.
• W2903033182 cites W2101437655 @default.
• W2903033182 cites W2102536917 @default.
• W2903033182 cites W2122914230 @default.
• W2903033182 cites W2123583989 @default.
• W2903033182 cites W2139077218 @default.
• W2903033182 cites W2139820762 @default.
• W2903033182 cites W2141987657 @default.
• W2903033182 cites W2148055818 @default.
• W2903033182 cites W2156908220 @default.
• W2903033182 cites W2160719369 @default.
• W2903033182 cites W2168685702 @default.
• W2903033182 cites W2270394595 @default.
• W2903033182 cites W2553087343 @default.
• W2903033182 cites W2570618306 @default.
• W2903033182 cites W2592145167 @default.
• W2903033182 cites W2598858091 @default.
• W2903033182 cites W2605286185 @default.
• W2903033182 cites W2606036476 @default.
• W2903033182 cites W2732908489 @default.
• W2903033182 cites W4210976084 @default.
• W2903033182 doi "https://doi.org/10.1038/s41389-018-0102-2" @default.
• W2903033182 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6255842" @default.
• W2903033182 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30478299" @default.
• W2903033182 hasPublicationYear "2018" @default.
• W2903033182 type Work @default.
• W2903033182 sameAs 2903033182 @default.
• W2903033182 citedByCount "24" @default.
• W2903033182 countsByYear W29030331822019 @default.
• W2903033182 countsByYear W29030331822020 @default.
• W2903033182 countsByYear W29030331822021 @default.
• W2903033182 countsByYear W29030331822022 @default.
• W2903033182 countsByYear W29030331822023 @default.
• W2903033182 crossrefType "journal-article" @default.
• W2903033182 hasAuthorship W2903033182A5000432967 @default.
• W2903033182 hasAuthorship W2903033182A5002004920 @default.
• W2903033182 hasAuthorship W2903033182A5007948709 @default.
• W2903033182 hasAuthorship W2903033182A5008989960 @default.
• W2903033182 hasAuthorship W2903033182A5034329447 @default.
• W2903033182 hasAuthorship W2903033182A5036274384 @default.
• W2903033182 hasAuthorship W2903033182A5049264813 @default.
• W2903033182 hasAuthorship W2903033182A5058203745 @default.
• W2903033182 hasAuthorship W2903033182A5073087120 @default.
• W2903033182 hasAuthorship W2903033182A5074339191 @default.
• W2903033182 hasAuthorship W2903033182A5077934134 @default.
• W2903033182 hasAuthorship W2903033182A5080012876 @default.
• W2903033182 hasAuthorship W2903033182A5082986499 @default.
• W2903033182 hasBestOaLocation W29030331821 @default.
• W2903033182 hasConcept C150903083 @default.
• W2903033182 hasConcept C178790620 @default.
• W2903033182 hasConcept C184235292 @default.
• W2903033182 hasConcept C185592680 @default.
• W2903033182 hasConcept C190283241 @default.
• W2903033182 hasConcept C207001950 @default.
• W2903033182 hasConcept C2778923194 @default.
• W2903033182 hasConcept C2780394083 @default.
• W2903033182 hasConcept C2780906345 @default.
• W2903033182 hasConcept C502942594 @default.
• W2903033182 hasConcept C55493867 @default.
• W2903033182 hasConcept C57074206 @default.
• W2903033182 hasConcept C71924100 @default.
• W2903033182 hasConcept C86803240 @default.
• W2903033182 hasConcept C98274493 @default.
• W2903033182 hasConceptScore W2903033182C150903083 @default.
• W2903033182 hasConceptScore W2903033182C178790620 @default.
• W2903033182 hasConceptScore W2903033182C184235292 @default.
• W2903033182 hasConceptScore W2903033182C185592680 @default.

• next